Supplementary Figure 1 from CXC Chemokine Receptor 3 Expression by Activated CD8+ T cells Is Associated with Survival in Melanoma Patients with Stage III Disease
Open Access
- 30 March 2023
- other
- Published by American Association for Cancer Research (AACR)
Abstract
Supplementary Figure 1 from CXC Chemokine Receptor 3 Expression by Activated CD8+ T cells Is Associated with Survival in Melanoma Patients with Stage III DiseaseKeywords
This publication has 0 references indexed in Scilit: